← 產業報告目錄

Closed System Drug Transfer Device (CSTD) Market Research Report Information By Type (Barrier Type and Filtration Type) by Closing Mechanism (Push to Turn System, Color-to-Color Alignment System, Leur Lock Systems, and Others), by Component (Vial Access Devices, Syringe Safety Devices, Bag/Infusion Set Devices, and Others), by Technology (Compartmentalize Devices, Diaphragm-based Devices, and Air Filtration Devices) by End User (Hospitals & Clinics, Specialty Centers, and Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Forecast to 2032

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2024-06-17頁數 139報告編號 MRF-a3de11f7b0

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Closed System Drug Transfer Device (CSTD) Market Research Report Information By Type (Barrier Type and Filtration Type) by Closing Mechanism (Push to Turn System, Color-to-Color Alignment System, Leur Lock Systems, and Others), by Component (Vial Access Devices, Syringe Safety Devices, Bag/Infusion Set Devices, and Others), by Technology (Compartmentalize Devices, Diaphragm-based Devices, and Air Filtration Devices) by End User (Hospitals & Clinics, Specialty Centers, and Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World)- Forecast to 2032 Market Overview During the forecast period (2024-2032), the Closed System Drug Transfer Device (CSTD) Market industry is expected to experience a compound annual growth rate (CAGR) of 17.51%, increasing from USD 0.99 billion in 2024 to USD 3.63 billion by 2032. The market growth is being driven by stringent regulatory requirements within the healthcare industry, as well as the increasing demand for CSTDs due to the increasing use of hazardous medications, oncology services, and home healthcare. The global healthcare landscape is substantially influenced by the escalating use of hazardous drugs in the healthcare sector. Approximately 8 million healthcare personnel in the United States, including pharmacy and nursing staff, physicians, operating room workers, environmental services workers, workers in research laboratories, veterinary care workers, and shipping and receiving personnel, are at risk of exposure to hazardous drugs, according to the Centers for Disease Control and Prevention. Additionally, the obligatory use of CSTDs during the complex processes of hazardous drug preparation and administration has been mandated by the stringent regulatory landscape established by healthcare authorities, including the U.S. Food and Drug Administration (FDA). This regulatory framework emphasizes the essential role that CSTDs play in mitigating exposure risks, thereby solidifying their market presence as an indispensable element of contemporary healthcare. Further, the integration of CSTDs into the standard operational procedures of healthcare facilities worldwide is further accelerated by the ever-expanding prevalence of chronic diseases and the heightened awareness of safety protocols. Market Segment Insights Barrier and filtration types comprise the Closed System Drug Transfer Device (CSTD) Market segmentation. The market is classified into push-to-turn systems, color-to-color alignment systems, leur lock systems, and others based on the closure mechanism. The market is segmented into vial access devices, syringe safety devices, bag/infusion set devices, and others in terms of component. The market is categorized into compartmentalize devices, diaphragm-based devices, and air filtration devices based on technology. The Closed System Drug Transfer Device (CSTD) Market segmentation is based on the end user, which includes hospitals & clinics, specialty centers, and others. Regional Perspectives In 2022, the North American closed system drug transfer device (CSTD) market held the largest market share. This is a result of the robust research and development infrastructure in the North American region and the rising prevalence of cancer cases. For example, in 2020, the United States reported 1,603,844 new cancer cases and 602,347 cancer fatalities. Due to the region's highly developed healthcare industry, prominent research and development infrastructure, and accessibility of CSTD products, the closed system drug transfer device (CSTD) market in Europe accounts for the second-largest market share. It is anticipated that the Asia-Pacific closed system drug transfer device (CSTD) market will experience substantial growth from 2024 to 2032. This is a result of the growing number of new vendors in the drug-device system, as there are numerous niche market participants who are attempting to capitalize on the market share. The Middle East, Africa, and Latin America comprise the Rest of the World. Due to the increasing costs of healthcare and the advancement of technology in the delivery of effective healthcare services, the closed system drug transfer device (CSTD) market in the regions is expected to experience growth. Major Players Becton, Dickinson and Company (US), BRAUN SE (Germany), Epic Medical (Singapore), JMS Co. Ltd (Japan), Equashield (US), ICU Medical, Inc (US), Yukon Medical (US), Simplivia Healthcare, Ltd. (Israel), Caragen Ltd (Ireland), and Corvida Medical (US) are among the key companies in the Closed System Drug Transfer Device (CSTD) Market.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 1.1 OVERVIEW 2 MARKET INTRODUCTION 2.1 DEFINITION 2.2 SCOPE OF THE STUDY 2.3 RESEARCH OBJECTIVE 2.4 MARKET STRUCTURE 2.5 ASSUMPTIONS & LIMITATIONS 3 RESEARCH METHODOLOGY 3.1 DATA MINING 3.2 SECONDARY RESEARCH 3.3 PRIMARY RESEARCH 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 3.5 FORECASTING TECHNIQUES 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 3.6.1 BOTTOM-UP APPROACH 3.6.2 TOP-DOWN APPROACH 3.7 DATA TRIANGULATION 3.8 VALIDATION 4 MARKET DYNAMICS 4.1 OVERVIEW 4.2 DRIVERS 4.2.1 INCREASING USE OF HAZARDOUS DRUGS 4.2.2 ONCOLOGY SERVICES AND HOME HEALTHCARE ARE INCREASING THE DEMAND FOR CSTDS 4.2.3 STRINGENT REGULATORY REQUIREMENTS WITHIN THE HEALTHCARE INDUSTRY 4.3 RESTRAINTS 4.3.1 HIGH INITIAL SETUP COSTS 4.4 OPPORTUNITY 4.4.1 INCREASING INVESTMENT IN HEALTHCARE INFRASTRUCTURE PRESENTS A SUBSTANTIAL OPPORTUNITY FOR THE MARKET 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 5.1.1 R&D 5.1.2 MANUFACTURING 5.1.3 DISTRIBUTION AND SALES 5.1.4 POST-SALES MONITORING 5.2 PORTER’S FIVE FORCES MODEL 5.2.1 THREAT OF NEW ENTRANTS 5.2.2 BARGAINING POWER OF SUPPLIERS 5.2.3 THREAT OF SUBSTITUTES 5.2.4 BARGAINING POWER OF BUYERS 5.2.5 INTENSITY OF RIVALRY 5.3 IMPACT OF COVID-19 ON THE GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET 5.3.1 IMPACT ON SUPPLY CHAIN 5.3.2 IMPACT ON KEY PLAYERS 5.3.3 IMPACT ON DEMAND AND SUPPLY 6 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE 6.1 OVERVIEW 6.2 BARRIER TYPE 6.3 FILTRATION TYPE 7 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM 7.1 OVERVIEW 7.2 PUSH TO TURN SYSTEM 7.3 COLOR-TO-COLOR ALIGNMENT SYSTEM 7.4 LEUR LOCK SYSTEMS 7.5 OTHERS 8 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT 8.1 OVERVIEW 8.2 VIAL ACCESS DEVICES 8.3 SYRINGE SAFETY DEVICES 8.4 BAG/INFUSION SET DEVICES 8.5 OTHERS 9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY 9.1 OVERVIEW 9.2 COMPARTMENTALIZE DEVICES 9.3 DIAPHRAGM-BASED DEVICES 9.4 AIR FILTRATION DEVICES 10 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 10.1 OVERVIEW 10.2 HOSPITALS & CLINICS 10.3 SPECIALTY CENTERS 10.4 OTHERS 11 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY REGION 11.1 OVERVIEW 11.2 NORTH AMERICA 11.2.1 US 11.2.2 CANADA 11.3 EUROPE 11.3.1 GERMANY 11.3.2 FRANCE 11.3.3 UK 11.3.4 ITALY 11.3.5 SPAIN 11.3.6 REST OF EUROPE 11.4 ASIA-PACIFIC 11.4.1 CHINA 11.4.2 JAPAN 11.4.3 INDIA 11.4.4 AUSTRALIA 11.4.5 SOUTH KOREA 11.4.6 REST OF ASIA-PACIFIC 11.5 REST OF THE WORLD 11.5.1 MIDDLE EAST 11.5.2 AFRICA 11.5.3 LATIN AMERICA 12 COMPETITIVE LANDSCAPE 12.1 OVERVIEW 12.2 COMPETITIVE BENCHMARKING 12.3 MAJOR GROWTH STRATEGY IN GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET 12.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET 12.5 KEY DEVELOPMENT ANALYSIS 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 12.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL 12.6.2 PARTNERSHIP /EXPANSION 12.7 MAJOR PLAYERS SALES ANALYSIS 12.7.1 SALES & OPERATING INCOME 12.8 MAJOR PLAYERS R&D ANALYSIS 13 COMPANY PROFILES 13.1 BECTON, DICKINSON, AND COMPANY 13.1.1 FINANCIAL OVERVIEW 13.1.2 PRODUCTS OFFERED 13.1.3 KEY DEVELOPMENTS 13.1.4 SWOT ANALYSIS 13.1.5 KEY STRATEGY 13.2 B. BRAUN SE 13.2.1 FINANCIAL OVERVIEW 13.2.2 PRODUCTS OFFERED 13.2.3 KEY DEVELOPMENTS 13.2.4 SWOT ANALYSIS 13.2.5 KEY STRATEGY 13.3 EPIC MEDICAL 13.3.1 FINANCIAL OVERVIEW 13.3.2 PRODUCTS OFFERED 13.3.3 KEY DEVELOPMENTS 13.3.4 KEY STRATEGIES 13.4 SIMPLIVIA HEALTHCARE, LTD. 13.4.1 FINANCIAL OVERVIEW 13.4.2 PRODUCTS OFFERED 13.4.3 KEY DEVELOPMENTS 13.4.4 KEY STRATEGIES 13.5 JMS CO.LTD. 13.5.1 FINANCIAL OVERVIEW 13.5.2 PRODUCTS OFFERED 13.5.3 KEY DEVELOPMENTS 13.5.4 KEY STRATEGIES 13.6 EQUASHIELD 13.6.1 COMPANY OVERVIEW 13.6.2 FINANCIAL OVERVIEW 13.6.3 PRODUCTS OFFERED 13.6.4 KEY DEVELOPMENTS 13.6.5 SWOT ANALYSIS 13.6.6 KEY STRATEGIES 13.7 ICU MEDICAL, INC 13.7.1 COMPANY OVERVIEW 13.7.2 FINANCIAL OVERVIEW 13.7.3 PRODUCTS OFFERED 13.7.4 KEY DEVELOPMENTS 13.7.5 SWOT ANALYSIS 13.7.6 KEY STRATEGIES 13.8 YUKON MEDICAL 13.8.1 COMPANY OVERVIEWS 13.8.2 FINANCIAL OVERVIEW 13.8.3 PRODUCTS OFFERED 13.8.4 KEY DEVELOPMENTS 13.8.5 SWOT ANALYSIS 13.8.6 KEY STRATEGIES 13.9 CARAGEN LTD 13.9.1 COMPANY OVERVIEW 13.9.2 FINANCIAL OVERVIEW 13.9.3 PRODUCTS OFFERED 13.9.4 KEY DEVELOPMENTS 13.9.5 KEY STRATEGIES 13.10 CORVIDA MEDICAL 13.10.1 COMPANY OVERVIEW 13.10.2 FINANCIAL OVERVIEW 13.10.3 PRODUCTS OFFERED 13.10.4 KEY DEVELOPMENTS 13.10.5 KEY STRATEGIES 14 APPENDIX 14.1 REFERENCES 14.2 RELATED REPORTS
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS TABLE 3 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 4 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR BARRIER TYPE, BY REGION, 2019–2032 (USD BILLION) TABLE 5 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR FILTRATION TYPE, BY REGION, 2019–2032 (USD BILLION) TABLE 6 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2019–2032 (USD BILLION) TABLE 7 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR PUSH TO TURN SYSTEM, BY REGION, 2019–2032 (USD BILLION) TABLE 8 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR COLOR-TO-COLOR ALIGNMENT SYSTEM, BY REGION, 2019–2032 (USD BILLION) TABLE 9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR LEUR LOCK SYSTEMS, BY REGION, 2019–2032 (USD BILLION) TABLE 10 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION) TABLE 11 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 12 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR VIAL ACCESS DEVICES, BY REGION, 2019–2032 (USD BILLION) TABLE 13 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR SYRINGE SAFETY DEVICES, BY REGION, 2019–2032 (USD BILLION) TABLE 14 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR BAG/INFUSION SET DEVICES, BY REGION, 2019–2032 (USD BILLION) TABLE 15 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION) TABLE 16 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 17 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR COMPARTMENTALIZE DEVICES, BY REGION, 2019–2032 (USD BILLION) TABLE 18 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR DIAPHRAGM-BASED DEVICES, BY REGION, 2019–2032 (USD BILLION) TABLE 19 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR AIR FILTRATION DEVICES, BY REGION, 2019–2032 (USD BILLION) TABLE 20 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 21 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019–2032 (USD BILLION) TABLE 22 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR SPECIALTY CENTERS, BY REGION, 2019–2032 (USD BILLION) TABLE 23 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD BILLION) TABLE 24 GLOBAL: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2019–2032 (USD BILLION) TABLE 25 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 26 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2019–2032 (USD BILLION) TABLE 27 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 28 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 29 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 30 US: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 31 US: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2019–2032 (USD BILLION) TABLE 32 US: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 33 US: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 34 US: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 35 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 36 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2019–2032 (USD BILLION) TABLE 37 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 38 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 39 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 40 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 41 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2019–2032 (USD BILLION) TABLE 42 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 43 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 44 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 45 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 46 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2019–2032 (USD BILLION) TABLE 47 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 48 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 49 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 50 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 51 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2019–2032 (USD BILLION) TABLE 52 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 53 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 54 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 55 UK: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 56 UK: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2019–2032 (USD BILLION) TABLE 57 UK: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 58 UK: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 59 UK: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 60 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 61 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2019–2032 (USD BILLION) TABLE 62 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 63 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 64 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 65 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 66 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2019–2032 (USD BILLION) TABLE 67 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 68 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 69 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 70 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 71 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2019–2032 (USD BILLION) TABLE 72 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 73 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 74 REST OF EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 75 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COUNTRY, 2019–2032 (USD BILLION) TABLE 76 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 77 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD BILLION) TABLE 78 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 79 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 80 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 81 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 82 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD BILLION) TABLE 83 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 84 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 85 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 86 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 87 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD BILLION) TABLE 88 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 89 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 90 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 91 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 92 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD BILLION) TABLE 93 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 94 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 95 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 96 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 97 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD BILLION) TABLE 98 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 99 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 100 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 101 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 102 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD BILLION) TABLE 103 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 104 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 105 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 106 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 107 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD BILLION) TABLE 108 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 109 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 110 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 111 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COUNTRY, 2019–2032 (USD BILLION) TABLE 112 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 113 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD BILLION) TABLE 114 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 115 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 116 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 117 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 118 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD BILLION) TABLE 119 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 120 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 121 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 122 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 123 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD BILLION) TABLE 124 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 125 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 126 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 127 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TYPE, 2019–2032 (USD BILLION) TABLE 128 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY CLOSING MECHANISM, 2019-2032 (USD BILLION) TABLE 129 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY COMPONENT, 2019–2032 (USD BILLION) TABLE 130 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION) TABLE 131 LATIN AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, BY END USER, 2019–2032 (USD BILLION) TABLE 132 MAJOR PLAYERS IN GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET TABLE 133 MOST ACTIVE PLAYER IN GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET TABLE 134 PRODUCT LAUNCH/ PRODUCT APPROVAL TABLE 135 PARTNERSHIP/EXPANSION TABLE 136 BECTON, DICKINSON AND COMPANY: PRODCUTS OFFERED TABLE 137 B. BRAUN SE: PRODUCTS OFFERED TABLE 138 B. BRAUN SE: KEY DEVELOPMENTS TABLE 139 EPIC MEDICAL: PRODUCTS OFFERED TABLE 140 SIMPLIVIA HEALTHCARE, LTD.: PRODUCTS OFFERED TABLE 141 SIMPLIVIA HEALTHCARE, LTD.: KEY DEVELOPMENTS TABLE 142 JMS CO.LTD. : PRODUCTS OFFERED TABLE 143 EQUASHIELD: PRODUCTS OFFERED TABLE 144 EQUASHIELD: KEY DEVELOPMENTS TABLE 145 ICU MEDICAL, INC: PRODUCTS OFFERED TABLE 146 YUKON MEDICAL: PRODUCTS OFFERED TABLE 147 YUKON MEDICAL: KEY DEVELOPMENTS TABLE 148 CARAGEN LTD: PRODUCTS OFFERED TABLE 149 CORVIDA MEDICAL: PRODUCTS OFFERED LIST OF FIGURES FIGURE 1 MARKET SYNOPSIS FIGURE 2 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES FIGURE 4 MARKET DYNAMICS: GLOBAL FOR CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FIGURE 5 DRIVER IMPACT ANALYSIS FIGURE 6 RESTRAINT IMPACT ANALYSIS FIGURE 7 VALUE CHAIN ANALYSIS OF THE CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FIGURE 9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, TYPE SEGMENT ATTRACTIVENESS, (USD BILLION) FIGURE 10 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2022 & 2032 (USD BILLION) FIGURE 11 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE (%), BY TYPE, 2022 FIGURE 12 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, CLOSING MECHANISM SEGMENT ATTRACTIVENESS, (USD BILLION) FIGURE 13 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY CLOSING MECHANISM, 2022 & 2032 (USD BILLION) FIGURE 14 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE (%), BY CLOSING MECHANISM, 2022 FIGURE 15 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, COMPONENT SEGMENT ATTRACTIVENESS, (USD BILLION) FIGURE 16 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT, 2022 & 2032 (USD BILLION) FIGURE 17 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE (%), BY COMPONENT, 2022 FIGURE 18 CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, TECHNOLOGY SEGMENT ATTRACTIVENESS, (USD BILLION) FIGURE 19 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TECHNOLOGY, 2022 & 2032 (USD BILLION) FIGURE 20 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE (%), BY TECHNOLOGY, 2022 FIGURE 21 CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET, END USER SEGMENT ATTRACTIVENESS, (USD BILLION) FIGURE 22 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2022 & 2032 (USD BILLION) FIGURE 23 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE (%), BY END USER, 2022 FIGURE 24 GLOBAL: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2022 & 2032 (USD BILLION) FIGURE 25 GLOBAL: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE (%), BY REGION, 2022 FIGURE 26 NORTH AMERICA MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, 2019-2032 (USD BILLION) FIGURE 27 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2022 & 2030 (USD BILLION) FIGURE 28 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2019–2030 (USD BILLION) FIGURE 29 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE (%), BY COUNTRY, 2022 FIGURE 30 EUROPE MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, 2019-2032 (USD BILLION) FIGURE 31 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2022 & 2030 (USD BILLION) FIGURE 32 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2019–2030 (USD BILLION) FIGURE 33 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE (%), BY COUNTRY, 2022 FIGURE 34 ASIA-PACIFIC MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, 2019-2032 (USD BILLION) FIGURE 35 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE, BY COUNTRY, 2022 (% SHARE) FIGURE 36 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE, BY COUNTRY, 2022 & 2032 (USD BILLION) FIGURE 37 REST OF THE WORLD MARKET ANALYSIS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, 2019-2032 (USD BILLION) FIGURE 38 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE, BY COUNTRY, 2022 (% SHARE) FIGURE 39 REST OF THE WORLD: CLOSED SYSTEM DRUG TRANSFER DEVICE MARKET SHARE, BY COUNTRY, 2022 & 2032 (USD BILLION) FIGURE 40 BENCHMARKING OF MAJOR COMPETITORS FIGURE 41 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FIGURE 42 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET: COMPETITIVE LANDSCAPE FIGURE 43 MAJOR PLAYERS SALES & OPERATING INCOME, 2022 FIGURE 44 MAJOR PLAYERS R&D EXPENDITURE, 2022 FIGURE 45 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT FIGURE 46 BECTON, DICKINSON, AND COMPANY: SWOT ANALYSIS FIGURE 47 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT FIGURE 48 B. BRAUN SE: SWOT ANALYSIS FIGURE 49 JMS CO.LTD.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 50 EQUASHIELD: SWOT ANALYSIS FIGURE 51 ICU MEDICAL, INC: FINANCIAL OVERVIEW SNAPSHOT FIGURE 52 ICU MEDICAL, INC: SWOT ANALYSIS FIGURE 53 YUKON MEDICAL: SWOT ANALYSIS

提及公司

BectonDickinson and Company (US)BRAUN SE (Germany)Epic Medical (Singapore)JMS Co. Ltd (Japan)Equashield (US)ICU MedicalInc (US)Yukon Medical (US)Simplivia HealthcareLtd. (Israel)Caragen Ltd (Ireland)and Corvida Medical (US)

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們